VANDA PHARMACEUTICALS INC. Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount
VANDA PHARMACEUTICALS INC. (VNDA) reported Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount of 5.50 million shares for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount · last filed 2026-08-06
- VANDA PHARMACEUTICALS INC. antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2026-06-30 was 5.50M shares, a 16.56% decline year-over-year.
- VANDA PHARMACEUTICALS INC. antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2026-03-31 was 6.42M shares, a 1.30% decline year-over-year.
- VANDA PHARMACEUTICALS INC. antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2025-09-30 was 5.45M shares, a 14.69% decline year-over-year.
- VANDA PHARMACEUTICALS INC. antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2025-06-30 was 6.59M shares, a 3.00% increase year-over-year.
- VANDA PHARMACEUTICALS INC. antidilutive securities excluded from computation of earnings per share, amount for fiscal 2025 was 6.08M shares, a 6.38% decline from fiscal 2024.
- VANDA PHARMACEUTICALS INC. antidilutive securities excluded from computation of earnings per share, amount for fiscal 2024 was 6.49M shares, a 0.45% increase from fiscal 2023.
- VANDA PHARMACEUTICALS INC. antidilutive securities excluded from computation of earnings per share, amount for fiscal 2023 was 6.46M shares, a 35.04% increase from fiscal 2022.
- VANDA PHARMACEUTICALS INC. antidilutive securities excluded from computation of earnings per share, amount for fiscal 2022 was 4.79M shares, a 119.89% increase from fiscal 2021.
| Period end | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 3 month | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 3 month as first filed | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 6 month | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 6 month as first filed | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 9 month | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 9 month as first filed | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 12 month | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | 5.50M shares 10-Q · filed 2026-08-06 | 5.96M shares 10-Q · filed 2026-08-06 | ||||||
| 2026-03-31 | 6.42M shares 10-Q · filed 2026-05-07 | |||||||
| 2025-12-31 | 6.08M shares 10-K · filed 2026-02-12 | |||||||
| 2025-09-30 | 5.45M shares 10-Q · filed 2025-10-30 | 6.18M shares 10-Q · filed 2025-10-30 | ||||||
| 2025-06-30 | 6.59M shares 10-Q · filed 2026-08-06 | 6.55M shares 10-Q · filed 2026-08-06 | ||||||
| 2025-03-31 | 6.51M shares 10-Q · filed 2026-05-07 | |||||||
| 2024-12-31 | 6.49M shares 10-K · filed 2026-02-12 | |||||||
| 2024-09-30 | 6.38M shares 10-Q · filed 2025-10-30 | 6.60M shares 10-Q · filed 2025-10-30 | ||||||
| 2024-06-30 | 6.40M shares 10-Q · filed 2025-07-31 | 6.71M shares 10-Q · filed 2025-07-31 | ||||||
| 2024-03-31 | 7.03M shares 10-Q · filed 2025-05-08 | |||||||
| 2023-12-31 | 6.46M shares 10-K · filed 2026-02-12 | |||||||
| 2023-09-30 | 6.72M shares 10-Q · filed 2024-11-07 | 6.53M shares 10-Q · filed 2024-11-07 | ||||||
| 2023-06-30 | 6.72M shares 10-Q · filed 2024-08-01 | 6.43M shares 10-Q · filed 2024-08-01 | ||||||
| 2023-03-31 | 6.13M shares 10-Q · filed 2024-05-09 | |||||||
| 2022-12-31 | 4.79M shares 10-K · filed 2025-02-14 | |||||||
| 2022-09-30 | 5.24M shares 10-Q · filed 2023-11-09 | 5.20M shares 10-Q · filed 2023-11-09 | ||||||
| 2022-06-30 | 5.39M shares 10-Q · filed 2023-07-28 | 4.98M shares 10-Q · filed 2023-07-28 | ||||||
| 2022-03-31 | 4.26M shares 10-Q · filed 2023-05-03 | |||||||
| 2021-12-31 | 2.18M shares 10-K · filed 2024-02-08 | |||||||
| 2021-09-30 | 2.23M shares 10-Q · filed 2022-11-03 | 2.19M shares 10-Q · filed 2022-11-03 | ||||||
| 2021-06-30 | 2.21M shares 10-Q · filed 2022-08-04 | 2.17M shares 10-Q · filed 2022-08-04 | ||||||
| 2021-03-31 | 2.14M shares 10-Q · filed 2022-05-06 | |||||||
| 2020-12-31 | 3.41M shares 10-K · filed 2023-02-09 | |||||||
| 2020-09-30 | 3.90M shares 10-Q · filed 2021-11-04 | 3.60M shares 10-Q · filed 2021-11-04 | ||||||
| 2020-06-30 | 3.81M shares 10-Q · filed 2021-07-29 | 3.45M shares 10-Q · filed 2021-07-29 | ||||||
| 2020-03-31 | 3.10M shares 10-Q · filed 2021-05-06 | |||||||
| 2019-12-31 | 1.93M shares 10-K · filed 2022-02-24 | |||||||
| 2019-09-30 | 2.65M shares 10-Q · filed 2020-10-29 | 1.83M shares 10-Q · filed 2020-10-29 | ||||||
| 2019-06-30 | 2.29M shares 10-Q · filed 2020-08-06 | 1.42M shares 10-Q · filed 2020-08-06 | ||||||
| 2019-03-31 | 3.07M shares 10-Q · filed 2020-05-07 | |||||||
| 2018-12-31 | 903.26K shares 10-K · filed 2021-02-11 | |||||||
| 2018-09-30 | 752.19K shares 10-Q · filed 2019-11-07 | 1.06M shares 10-Q · filed 2019-11-07 | ||||||
| 2018-06-30 | 1.36M shares 10-Q · filed 2019-08-01 | 1.21M shares 10-Q · filed 2019-08-01 | ||||||
| 2018-03-31 | 1.06M shares 10-Q · filed 2019-05-03 | |||||||
| 2017-12-31 | 3.14M shares 10-K · filed 2020-02-26 | |||||||
| 2017-09-30 | 3.11M shares 10-Q · filed 2018-11-07 | 3.23M shares 10-Q · filed 2018-11-07 | ||||||
| 2017-06-30 | 3.41M shares 10-Q · filed 2018-08-02 | 3.29M shares 10-Q · filed 2018-08-02 | ||||||
| 2017-03-31 | 3.16M shares 10-Q · filed 2018-05-02 | |||||||
| 2016-12-31 | 4.94M shares 10-K · filed 2019-02-19 | |||||||
| 2016-09-30 | 3.85M shares 10-Q · filed 2017-11-08 | 5.30M shares 10-Q · filed 2017-11-08 | ||||||
| 2016-06-30 | 5.80M shares 10-Q · filed 2017-08-03 | 6.02M shares 10-Q · filed 2017-08-03 | ||||||
| 2016-03-31 | 6.25M shares 10-Q · filed 2017-05-03 | |||||||
| 2015-12-31 | 5.66M shares 10-K · filed 2018-02-15 | |||||||
| 2015-09-30 | 5.18M shares 10-Q · filed 2016-11-03 | 5.53M shares 10-Q · filed 2016-11-03 | ||||||
| 2015-06-30 | 5.77M shares 10-Q · filed 2016-07-28 | 5.71M shares 10-Q · filed 2016-07-28 | ||||||
| 2015-03-31 | 5.66M shares 10-Q · filed 2016-05-05 | |||||||
| 2014-12-31 | 3.52M shares 10-K · filed 2017-02-17 | |||||||
| 2014-09-30 | 3.73M shares 10-Q · filed 2015-11-04 | 3.78M shares 10-Q · filed 2015-11-04 | ||||||
| 2014-06-30 | 3.74M shares 10-Q · filed 2015-07-31 | 3.81M shares 10-Q · filed 2015-07-31 | ||||||
| 2014-03-31 | 3.87M shares 10-Q · filed 2015-05-07 | |||||||
| 2013-12-31 | 4.41M shares 10-K · filed 2016-02-12 | 4.44M shares 10-K · filed 2014-02-25 | ||||||
| 2013-09-30 | 3.52M shares 10-Q · filed 2014-10-27 | 3.80M shares 10-Q · filed 2013-11-08 | 4.50M shares 10-Q · filed 2014-10-27 | 4.56M shares 10-Q · filed 2013-11-08 | ||||
| 2013-06-30 | 4.23M shares 10-Q · filed 2014-08-08 | 4.12M shares 10-Q · filed 2013-07-31 | 5.00M shares 10-Q · filed 2014-08-08 | 4.93M shares 10-Q · filed 2013-07-31 | ||||
| 2013-03-31 | 5.76M shares 10-Q · filed 2014-05-08 | 5.75M shares 10-Q · filed 2013-05-10 | ||||||
| 2012-12-31 | 5.46M shares 10-K · filed 2015-03-13 | 5.22M shares 10-K · filed 2013-02-26 | ||||||
| 2012-09-30 | 5.15M shares 10-Q · filed 2013-11-08 | 5.18M shares 10-Q · filed 2013-11-08 | ||||||
| 2012-06-30 | 5.20M shares 10-Q · filed 2013-07-31 | 5.20M shares 10-Q · filed 2013-07-31 | ||||||
| 2012-03-31 | 5.20M shares 10-Q · filed 2013-05-10 | |||||||
| 2011-12-31 | 4.56M shares 10-K · filed 2014-02-25 | |||||||
| 2011-09-30 | 4.04M shares 10-Q · filed 2012-11-08 | 3.72M shares 10-Q · filed 2012-11-08 | ||||||
| 2011-06-30 | 3.97M shares 10-Q · filed 2012-08-03 | 3.56M shares 10-Q · filed 2012-08-03 | ||||||
| 2010-12-31 | 3.02M shares 10-K · filed 2013-02-26 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| STANDARD BIOTOOLS INC. (LAB) | United States | $0.297B | 3.80 |
| ROCKET PHARMACEUTICALS, INC. (RCKT) | United States | $0.296B | -21.78 |
| GT Biopharma, Inc. (GTBP) | United States | $0.309B | -4.58 |
| ABEONA THERAPEUTICS INC. (ABEO) | United States | $0.312B | -5.63 |
| Fulcrum Therapeutics, Inc. (FULC) | United States | $0.289B | -3.28 |
| Contineum Therapeutics, Inc. (CTNM) | United States | $0.289B | -4.40 |
| Prelude Therapeutics Inc (PRLD) | United States | $0.318B | -7.01 |
| Perspective Therapeutics, Inc. (CATX) | United States | $0.284B | -3.34 |
| Evommune, Inc. (EVMN) | United States | $0.320B | -5.10 |
| Upstream Bio, Inc. (UPB) | United States | $0.284B | -2.42 |